Sceolex Pharma Private Limited

Sceolex Pharma Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U24110KA2012PTC066676 Incorporated 13 November 2012 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company pharma
Revenue · FY 2025
₹1.12 Cr
▼ 37% YoY
Net loss · FY 2025
₹9.38 Lakh
Net margin -8.4%
EBITDA · FY 2025
-₹9.15 Lakh
EBITDA margin -8.2%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Sceolex Pharma Private Limited

Data last updated:

Sceolex Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 November 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24110KA2012PTC066676. Its GSTIN is 29AASCS3600F1Z8 (Karnataka).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Bellur Mekhala Dwarakanath and Sankara Guha Dwarakanath Bellur.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 135/2 Bearing Bbmp Khatha No. 18 Guava Garden 5th Block Koramangala, Bengaluru, Karnataka, India – 560095.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a decline of 37% compared to the previous year. For the same year it recorded a net loss of ₹9.38 Lakh (net margin -8.4%) and EBITDA of -₹9.15 Lakh (EBITDA margin -8.2%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 24% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24110KA2012PTC066676
Registration Number 066676
Incorporation Date 13 November 2012
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Sceolex Pharma Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    No. 135/2 Bearing Bbmp Khatha No. 18 Guava Garden 5th Block Koramangala, Bengaluru, Karnataka, India – 560095
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Sceolex Pharma Private Limited, buy the company report.

Comprehensive company report
Sceolex Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sceolex Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Sceolex Pharma Private Limited, buy the company report.

Financials of Sceolex Pharma Private Limited

FY 2025 filings available

Sceolex Pharma Private Limited reported revenue of ₹1.12 Cr (down 37% YoY) for FY 2025.

Revenue · FY 2025
₹1.12 Cr ▼ 37%
Net loss · FY 2025
₹9.38 Lakh margin -8.4%
EBITDA · FY 2025
-₹9.15 Lakh margin -8.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 37%
3 years · compounded
▲ 61%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 76%
3 years · compounded
▼ 82%
5 years · compounded
▼ 36%

Revenue fell 37% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹9.15 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹9.38 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-8.2%
Net Profit Margin-8.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sceolex Pharma Private Limited, buy the company report.

Board of directors of Sceolex Pharma Private Limited

Sceolex Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bellur Mekhala DwarakanathDirector01 Nov 201313 Years 0 MonthsCurrent
Sankara Guha Dwarakanath BellurDirector01 Nov 201313 Years 0 MonthsCurrent
Surayanarayanarao SavithriDirector01 Nov 201313 Years 0 MonthsCurrent

Auditor

Sceolex Pharma Private Limited is audited by NITYANANDA & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
NITYANANDA & COFY 2020012595S

Shareholding

The shareholding of Sceolex Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sceolex Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sceolex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sceolex Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AASCS3600F1Z8KarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Sceolex Pharma Private Limited, buy the company report.

Recent activity

Sceolex Pharma Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Raju Chowdappa Raghavendra ceased to be Director on 09 Jun 2015.

AGM
Sceolex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sceolex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Raju Chowdappa Raghavendra ceased to be Director.
Ceased
Arun Nagesh Avadhani ceased to be Additional Director.
Ceased
Bellur Mekhala Dwarakanath ceased to be Additional Director.
Ceased
Sankara Guha Dwarakanath Bellur ceased to be Additional Director.
Ceased
Surayanarayanarao Savithri ceased to be Additional Director.
Appointed
Bellur Mekhala Dwarakanath was appointed as Director.
Ceased
Muniswamaiah Krishnamurthy ceased to be Director.
Appointed
Sankara Guha Dwarakanath Bellur was appointed as Director.
Appointed
Surayanarayanarao Savithri was appointed as Director.
Incorporation
13 Nov 2012
Sceolex Pharma Private Limited was registered on 13 Nov 2012 with Roc Bangalore & aged 14 years 7 days as per MCA records.

Frequently asked questions

Sceolex Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 November 2012 (14+ years old) and is registered under CIN U24110KA2012PTC066676.

Sceolex Pharma has 3 current directors:

The latest financial statements of Sceolex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sceolex Pharma is 29AASCS3600F1Z8, registered in Karnataka.

The CIN (Corporate Identification Number) of Sceolex Pharma is U24110KA2012PTC066676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sceolex Pharma was incorporated on 13 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.

Raju Chowdappa Raghavendra ceased to be Director on 09 Jun 2015. Arun Nagesh Avadhani ceased to be Additional Director on 10 May 2014. Bellur Mekhala Dwarakanath ceased to be Additional Director on 10 May 2014. Sceolex Pharma has 9 board changes on record in total.

The registered office of Sceolex Pharma is at No. 1352 Bearing Bbmp Khatha No. 18 Guava Garden 5th Block Koramangala, Bengaluru, Karnataka, India – 560095.

Sceolex Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Sceolex Pharma is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.